• Pharmacology
  • Allergy, Immunology, and ENT
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious Diseases
  • Neurology
  • OB/GYN
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Mental, Behavioral and Development Health
  • Oncology
  • Rheumatology
  • Sexual Health
  • Pain

HPV vaccine program renewed

Article

A program with the goal of expanding human papillomavirus (HPV) vaccination and preventing HPV-related cancers has been expanded.

Eliminating the public health threat of cancers linked to human papillomavirus (HPV) has been a key program of the American Cancer Society. The organization decided to renew their program Mission: HPV Cancer Free with the hope that it could keep HPV vaccination levels on track.

The program’s goal is to reach a vaccination rate of 80% of adolescents aged 13 years receiving it by 2026. A recent report found a 71% drop in the number of health care visits involving patients aged 7 to 17 years.

Roughly 14 million people in the United States are infect by HPV every year and overall 8 in 10 people will be infected with HPV at some point in their lifetime. The vaccine performs best when administered to children aged 9 to 12 years. In fact, 2 doses of the vaccine administered at this point of life can prevent more than 90% of HPV-related cancers.

For more on the renewal, check out our sister publication Contemporary Clinic.

Related Videos
Natasha Hoyte, MPH, CPNP-PC
Importance of maternal influenza vaccination recommendations
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Samantha Olson, MPH
Deborah Persaud, MD
© 2024 MJH Life Sciences

All rights reserved.